Literature DB >> 32445925

CircFOXO3 functions as a molecular sponge for miR-143-3p to promote the progression of gastric carcinoma via upregulating USP44.

Tian Xiang1, Hong-Sheng Jiang2, Bi-Tao Zhang3, Gao Liu4.   

Abstract

Gastric carcinoma (GC) ranks fifth in terms of cancer morbidity and third in cancer-related death worldwide and imposes enormous health and economic burdens. The molecular mechanisms underlying GC formation and progression remain unclear. Our aim was to identify the involvement of circular RNA circFOXO3 in GC, and to determine the underlying mechanisms. In this study, we revealed a stimulatory role of circular RNA circFOXO3 in tumor growth in vivo. CircFOXO3 enhanced GC cell proliferation and migration in vitro and promoted tumor growth of GC cells in vivo. Bioinformatic analysis revealed that circFOXO3 might regulate USP44 expression by specifically binding to microRNA (miR)-143-3p. Existence of circFOXO3-miR-143-3p-USP44 axis in GC cells was confirmed by RNA-binding protein immunoprecipitation, luciferase reporter assay, and an RNA pull-down experiments. All the data indicate that circFOXO3 promotes GC cell proliferation and migration by upregulating USP44 expression via targeting of miR-143-3p.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gastric carcinoma; USP44; circFOXO3; circRNA; miR-143-3p

Year:  2020        PMID: 32445925     DOI: 10.1016/j.gene.2020.144798

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

Review 1.  Circular RNAs and Drug Resistance in Genitourinary Cancers: A Literature Review.

Authors:  Gongwei Long; Siquan Ma; Runlin Shi; Yi Sun; Zhiquan Hu; Ke Chen
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

2.  The Potential Role of IL1RAP on Tumor Microenvironment-Related Inflammatory Factors in Stomach Adenocarcinoma.

Authors:  Qing Lv; Qinghua Xia; Anshu Li; Zhiyong Wang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

3.  CircMMP11 overexpression predicts the poor survival of non-small cell lung cancer and downregulates miR-143 through methylation to suppress cell proliferation.

Authors:  Juan Chen; Jiang Gong
Journal:  J Cardiothorac Surg       Date:  2021-11-08       Impact factor: 1.637

4.  Circular RNA Foxo3 enhances progression of ovarian carcinoma cells.

Authors:  Li Wang; Jing Chen; Chunhua Lu
Journal:  Aging (Albany NY)       Date:  2021-09-23       Impact factor: 5.682

Review 5.  Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs.

Authors:  Pieterjan Ginckels; Paul Holvoet
Journal:  Yale J Biol Med       Date:  2022-03-31

6.  Circular RNA Foxo3 Relieves Myocardial Ischemia/Reperfusion Injury by Suppressing Autophagy via Inhibiting HMGB1 by Repressing KAT7 in Myocardial Infarction.

Authors:  Guang Sun; Jian-Fen Shen; Xiu-Fang Wei; Guo-Xian Qi
Journal:  J Inflamm Res       Date:  2021-12-01

7.  circFOXO3 Induced by KLF16 Modulates Clear Cell Renal Cell Carcinoma Growth and Natural Killer Cell Cytotoxic Activity through Sponging miR-29a-3p and miR-122-5p.

Authors:  Fafen Yang; Yuke Chen; Linxue Luo; Shengbin Nong; Tong Li
Journal:  Dis Markers       Date:  2022-08-29       Impact factor: 3.464

Review 8.  The Emerging Roles of circFOXO3 in Cancer.

Authors:  Dean Rao; Chengpeng Yu; Jiaqi Sheng; Enjun Lv; Wenjie Huang
Journal:  Front Cell Dev Biol       Date:  2021-06-04

9.  CRAFT: a bioinformatics software for custom prediction of circular RNA functions.

Authors:  Anna Dal Molin; Enrico Gaffo; Valeria Difilippo; Alessia Buratin; Caterina Tretti Parenzan; Silvia Bresolin; Stefania Bortoluzzi
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

10.  Circular RNA circFOXO3 regulates KDM2A by targeting miR-214 to promote tumor growth and metastasis in oral squamous cell carcinoma.

Authors:  Yilong Ai; Siyuan Wu; Chen Zou; Haigang Wei
Journal:  J Cell Mol Med       Date:  2021-06-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.